Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer …
A Anota, A Pozet, H Lemasson, FE Cotté, A Falcoz… - Quality of Life Research - Springer
Aim A systematic literature review of immuno-oncology trials was conducted to assess the
potential impact of open-label vs double-blind trial design on patient-reported outcome …
potential impact of open-label vs double-blind trial design on patient-reported outcome …
Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer …
A Anota, A Pozet, H Lemasson, FE Cotté… - Quality of Life …, 2021 - europepmc.org
Aim A systematic literature review of immuno-oncology trials was conducted to assess the
potential impact of open-label vs double-blind trial design on patient-reported outcome …
potential impact of open-label vs double-blind trial design on patient-reported outcome …
Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer …
A Anota, A Pozet, H Lemasson… - Quality of life …, 2022 - pubmed.ncbi.nlm.nih.gov
Aim A systematic literature review of immuno-oncology trials was conducted to assess the
potential impact of open-label vs double-blind trial design on patient-reported outcome …
potential impact of open-label vs double-blind trial design on patient-reported outcome …
Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer …
A Amélie, P Astrid, L Hervé… - Quality of Life …, 2022 - search.proquest.com
Aim A systematic literature review of immuno-oncology trials was conducted to assess the
potential impact of open-label vs double-blind trial design on patient-reported outcome …
potential impact of open-label vs double-blind trial design on patient-reported outcome …
Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer …
A Anota, A Pozet, H Lemasson, FE Cotté… - Quality of Life …, 2022 - search.ebscohost.com
Aim: A systematic literature review of immuno-oncology trials was conducted to assess the
potential impact of open-label vs double-blind trial design on patient-reported outcome …
potential impact of open-label vs double-blind trial design on patient-reported outcome …